de Boer JP - Search Results

1

Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodine.

Mohan V, Bruin NM, Tesselaar MET, de Boer JP, Vegt E, Hendrikx JJMA, Al-Mamgani A, van de Kamer JB, Sonke JJ, Vogel WV. Mohan V, et al. Among authors: de boer jp. EJNMMI Res. 2021 Mar 12;11(1):25. doi: 10.1186/s13550-021-00770-1. EJNMMI Res. 2021. PMID: 33710423 Free PMC article.

2

PSMA PET/CT Identifies Intrapatient Variation in Salivary Gland Toxicity From Iodine-131 Therapy.

Mohan V, Vogel WV, Valk GD, de Boer JP, Lam MGEH, de Keizer B. Mohan V, et al. Among authors: de boer jp, de keizer b. Mol Imaging. 2020 Jan-Dec;19:1536012120934992. doi: 10.1177/1536012120934992. Mol Imaging. 2020. PMID: 32619138 Free PMC article.

3

The impact of cumulative dose of cisplatin on outcome of patients with head and neck squamous cell carcinoma.

Al-Mamgani A, de Ridder M, Navran A, Klop WM, de Boer JP, Tesselaar ME. Al-Mamgani A, et al. Among authors: de ridder m, de boer jp. Eur Arch Otorhinolaryngol. 2017 Oct;274(10):3757-3765. doi: 10.1007/s00405-017-4687-4. Epub 2017 Jul 28. Eur Arch Otorhinolaryngol. 2017. PMID: 28755023

4

Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study.

Driessen CM, de Boer JP, Gelderblom H, Rasch CR, de Jong MA, Verbist BM, Melchers WJ, Tesselaar ME, van der Graaf WT, Kaanders JH, van Herpen CM. Driessen CM, et al. Among authors: de jong ma, de boer jp. Eur J Cancer. 2016 Jan;52:77-84. doi: 10.1016/j.ejca.2015.09.024. Epub 2015 Dec 1. Eur J Cancer. 2016. PMID: 26655558 Free article. Clinical Trial.

5

Laryngo-esophageal dysfunction free survival and propensity score matched analysis comparing organ preservation and total laryngectomy in hypopharynx cancer.

Petersen JF, Arends CR, van der Noort V, Al-Mamgani A, de Boer JP, Stuiver MM, van den Brekel MWM. Petersen JF, et al. Among authors: de boer jp. Oral Oncol. 2019 Aug;95:143-149. doi: 10.1016/j.oraloncology.2019.06.018. Epub 2019 Jun 22. Oral Oncol. 2019. PMID: 31345382

6

Definitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavity.

Elbers JBW, Al-Mamgani A, Paping D, van den Brekel MWM, Jóźwiak K, de Boer JP, Karakullukcu B, Verheij M, Zuur CL. Elbers JBW, et al. Among authors: de boer jp. Oral Oncol. 2017 Dec;75:163-168. doi: 10.1016/j.oraloncology.2017.11.006. Oral Oncol. 2017. PMID: 29224815

7

Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.

Elbers JBW, Al-Mamgani A, van den Brekel MWM, Jóźwiak K, de Boer JP, Lohuis PJFM, Willems SM, Verheij M, Zuur CL. Elbers JBW, et al. Among authors: de boer jp. Otolaryngol Head Neck Surg. 2019 Jun;160(6):1023-1033. doi: 10.1177/0194599818818443. Epub 2018 Dec 11. Otolaryngol Head Neck Surg. 2019. PMID: 30526317

8

Dysphagia, trismus and speech impairment following radiation-based treatment for advanced stage oropharyngeal carcinoma: a one-year prospective evaluation.

Karsten RT, Chargi N, van der Molen L, van Son RJJH, de Bree R, Al-Mamgani A, de Boer JP, Hilgers FJM, van den Brekel MWM, Smeele LE, Stuiver MM. Karsten RT, et al. Among authors: de boer jp, de bree r. Eur Arch Otorhinolaryngol. 2022 Feb;279(2):1003-1027. doi: 10.1007/s00405-021-06870-x. Epub 2021 May 27. Eur Arch Otorhinolaryngol. 2022. PMID: 34043065

9

Sarcopenia, a strong determinant for prolonged feeding tube dependency after chemoradiotherapy for head and neck cancer.

Karsten RT, Al-Mamgani A, Bril SI, Tjon-A-Joe S, van der Molen L, de Boer JP, Hilgers FJM, Smeele LE, van den Brekel MWM, Stuiver MM. Karsten RT, et al. Among authors: de boer jp. Head Neck. 2019 Nov;41(11):4000-4008. doi: 10.1002/hed.25938. Epub 2019 Aug 31. Head Neck. 2019. PMID: 31472000

10

From reactive to proactive tube feeding during chemoradiotherapy for head and neck cancer: A clinical prediction model-based approach.

Karsten RT, Stuiver MM, van der Molen L, Navran A, de Boer JP, Hilgers FJM, Klop WMC, Smeele LE. Karsten RT, et al. Among authors: de boer jp. Oral Oncol. 2019 Jan;88:172-179. doi: 10.1016/j.oraloncology.2018.11.031. Epub 2018 Dec 7. Oral Oncol. 2019. PMID: 30616790

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page